Fig. 1 · Structure
Documents & Downloads
Nefopam hydrochloride
Centrally Acting Analgesic Drug
Nefopam hydrochloride is a centrally acting non-opioid analgesic that provides relief from moderate to severe pain. It functions primarily by targeting β-catenin protein levels in mesenchymal cells, demonstrating efficacy in both in vitro and in vivo models. This compound is of significant interest in pain research and may offer alternative mechanisms for analgesia without the side effects commonly associated with opioid treatments.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 23327-57-3 |
| Applications | Centrally Acting Analgesic Drug |
| Formula | C17H20ClNO |
| Molecular Weight | 289.80 |
| Synonyms | Fenazoxine hydrochloride |
| SMILES | CN1CCOC(C2=CC=CC=C2)C3=CC=CC=C3C1.[H]Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.